"Developing a Novel Prognostic Model to Predict Overall Survival (OS) and 90 Day Mortality Rate (90DM) for Metastatic Colorectal Cancer (mCRC) Patients in Phase I Trials" by Santiago Aparo

Article

Developing a Novel Prognostic Model to Predict Overall Survival (OS) and 90 Day Mortality Rate (90DM) for Metastatic Colorectal Cancer (mCRC) Patients in Phase I Trials

Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting (2015)

Santiago Aparo, Baptist Health South Florida
Gopichand Pendurti
Umang H. Shah, Albert Einstein College of Medicine
Umang Swami, Albert Einstein College of Medicine
Yijuan Hou
Mohammad Haroon Ghalib, Montefiore Medical Center
Imran Chaudhary, Montefiore Medical Center

Link

Disciplines

Medicine and Health Sciences

Publication Date

2015

Citation Information

Santiago Aparo, Gopichand Pendurti, Umang H. Shah, Umang Swami, et al.. "Developing a Novel Prognostic Model to Predict Overall Survival (OS) and 90 Day Mortality Rate (90DM) for Metastatic Colorectal Cancer (mCRC) Patients in Phase I Trials" Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting Vol. 33 Iss. 15_suppl. (2015)
Available at: http://works.bepress.com/santiago-aparo/40/